{
    "results": [
        {
            "Model": "gpt-3.5-turbo",
            "correct_size": 50,
            "failed_size": 0,
            "Precited": [
                {
                    "inclusion_biomarker": [
                        [
                            "BTK alteration",
                            "FL alteration",
                            "MZL alteration",
                            "MCL alteration",
                            "CLL/SLL alteration"
                        ],
                        [
                            "HBV negative status"
                        ],
                        [
                            "HCV negative status"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "HIV positive status"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "NPM1 alteration"
                        ],
                        [
                            "KMT2A alteration"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "ALK translocation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "DLBCL"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Bone marrow involvement",
                            "Lymphoma cells",
                            "Liver function",
                            "Kidney function",
                            "Heart disease",
                            "Heart function",
                            "Other tumors",
                            "Psychological conditions"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "expression"
                        ],
                        [
                            "TMB-H",
                            "TMB-L"
                        ],
                        [
                            "MSI",
                            "MSI-H",
                            "MSI-L",
                            "MSS",
                            "microsatellite stable"
                        ],
                        [
                            "HER2"
                        ],
                        [
                            "HR"
                        ],
                        [
                            "ER"
                        ],
                        [
                            "PgR"
                        ],
                        [
                            "PD-L1 positive",
                            "PD-L1 negative status"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "alteration"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "BRAF mutation"
                        ],
                        [
                            "PD-1/PD-L1 inhibitor"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Autoimmune disease"
                        ],
                        [
                            "CNS metastases"
                        ],
                        [
                            "Systemic infections"
                        ],
                        [
                            "Major surgery"
                        ],
                        [
                            "Invasive malignancy"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD30 expression"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD19"
                        ],
                        [
                            "DLBCL",
                            "PMLBCL",
                            "TFL",
                            "HGBCL",
                            "Follicular Lymphoma"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Common variable immunodeficiency"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "platelets"
                        ],
                        [
                            "creatinine"
                        ],
                        [
                            "bilirubin"
                        ],
                        [
                            "INR"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "extrahepatic disease"
                        ],
                        [
                            "hepatic artery catheterization"
                        ],
                        [
                            "vascular abnormalities"
                        ],
                        [
                            "bleeding diathesis"
                        ],
                        [
                            "allergy to contrast dye"
                        ],
                        [
                            "concurrent malignancy"
                        ],
                        [
                            "refractory ascites"
                        ],
                        [
                            "external beam radiation"
                        ],
                        [
                            "uncorrectable flow to the gastrointestinal tract"
                        ],
                        [
                            "radiation to the lung"
                        ],
                        [
                            "angiography"
                        ],
                        [
                            "Tc-99 microaggregated albumin scan"
                        ],
                        [
                            "shunt fraction"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PIK3CA mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PD-1 pathway alteration"
                        ],
                        [
                            "LAG-3 pathway alteration"
                        ],
                        [
                            "Tumor PD-L1 expression"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "EGFR alteration"
                        ],
                        [
                            "ALK alteration"
                        ],
                        [
                            "ROS1 alteration"
                        ],
                        [
                            "BRAFV600E alteration"
                        ],
                        [
                            "NTRK alteration"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "B-ALL"
                        ],
                        [
                            "T-ALL"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD19 expression"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PIK3CA mutation"
                        ],
                        [
                            "PIK3CB mutation"
                        ],
                        [
                            "PIK3CD mutation"
                        ],
                        [
                            "PIK3CG mutation"
                        ],
                        [
                            "PIK3R1 mutation"
                        ],
                        [
                            "PIK3R2 mutation"
                        ],
                        [
                            "PIK3R3 mutation"
                        ],
                        [
                            "PIK3C2G mutation"
                        ],
                        [
                            "PIK3C3 mutation"
                        ],
                        [
                            "INPP4A mutation"
                        ],
                        [
                            "INPP4B mutation"
                        ],
                        [
                            "INPPL1 mutation"
                        ],
                        [
                            "INPP5D mutation"
                        ],
                        [
                            "PTEN mutation"
                        ],
                        [
                            "AKT1 mutation"
                        ],
                        [
                            "AKT2 mutation"
                        ],
                        [
                            "AKT3 mutation"
                        ],
                        [
                            "MTOR mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "RET alteration"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "MTAP homozygous deletion"
                        ]
                    ],
                    "exclusion_biomarker": [
                        "PRMT5 inhibitor therapy",
                        "MAT2A inhibitor therapy"
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "FGFR1 fusion",
                            "FGFR2 fusion",
                            "FGFR3 fusion"
                        ],
                        [
                            "FGFR1 P150S mutation",
                            "FGFR1 T340M mutation",
                            "FGFR1 R445W mutation",
                            "FGFR1 N546K mutation",
                            "FGFR1 K656E mutation"
                        ],
                        [
                            "FGFR2 C62Y mutation",
                            "FGFR2 A67V mutation",
                            "FGFR2 N82K mutation",
                            "FGFR2 D101Y mutation",
                            "FGFR2 E160K mutation",
                            "FGFR2 E163K mutation",
                            "FGFR2 M186T mutation",
                            "FGFR2 R203H mutation",
                            "FGFR2 R210Q mutation",
                            "FGFR2 Q212K mutation",
                            "FGFR2 R251Q mutation",
                            "FGFR2 S252W mutation",
                            "FGFR2 P253R mutation",
                            "FGFR2 P253L mutation",
                            "FGFR2 A264T mutation",
                            "FGFR2 W290C mutation",
                            "FGFR2 K310R mutation",
                            "FGFR2 Y328N mutation",
                            "FGFR2 G364E mutation",
                            "FGFR2 Y375C mutation",
                            "FGFR2 C382R mutation",
                            "FGFR2 A389T mutation",
                            "FGFR2 V392A mutation",
                            "FGFR2 R399Q mutation",
                            "FGFR2 H416R mutation",
                            "FGFR2 I422V mutation",
                            "FGFR2 H544Q mutation",
                            "FGFR2 N549H mutation",
                            "FGFR2 N549K mutation",
                            "FGFR2 N549D mutation",
                            "FGFR2 N549S mutation",
                            "FGFR2 L560F mutation",
                            "FGFR2 K659E mutation",
                            "FGFR2 K659N mutation",
                            "FGFR2 R664W mutation",
                            "FGFR2 E718K mutation",
                            "FGFR2 S791T mutation"
                        ],
                        [
                            "FGFR3 G380E mutation",
                            "FGFR3 G380R mutation",
                            "FGFR3 A391E mutation",
                            "FGFR3 K650T mutation",
                            "FGFR3 K650E mutation",
                            "FGFR3 K650Q mutation",
                            "FGFR3 K650N mutation"
                        ],
                        [
                            "FGFR1 amplification",
                            "FGFR2 amplification",
                            "FGFR3 amplification"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Brain metastases",
                            "Subdural metastases",
                            "Leptomeningeal metastases",
                            "Primary CNS tumor in cerebellum",
                            "Primary CNS tumor in brainstem",
                            "Primary CNS tumor in spinal cord",
                            "Primary CNS tumor in pituitary gland",
                            "Primary CNS tumor in optic nerve",
                            "Primary CNS tumor in olfactory nerve"
                        ],
                        [
                            "Positive for HIV antibody",
                            "Positive for HBs antigen",
                            "Positive for HCV antibody"
                        ],
                        [
                            "Child-Pugh score B",
                            "Child-Pugh score C"
                        ],
                        [
                            "Pericardial effusion requiring treatment",
                            "Pleural effusion requiring treatment",
                            "Ascites requiring treatment"
                        ],
                        [
                            "Grade 2 or higher corneal disorders",
                            "Active retinopathy"
                        ],
                        [
                            "Toxicity of previous treatment not recovered to Grade 1 or lower"
                        ],
                        [
                            "FGFR1 V561 gatekeeper mutation",
                            "FGFR2 V564/565 gatekeeper mutation",
                            "FGFR3 V555/557 gatekeeper mutation",
                            "FGFR4 V550 gatekeeper mutation"
                        ],
                        [
                            "Coexisting driver gene abnormalities: KRAS",
                            "Coexisting driver gene abnormalities: NRAS",
                            "Coexisting driver gene abnormalities: EGFR",
                            "Coexisting driver gene abnormalities: BRAF V600",
                            "Coexisting driver gene abnormalities: ALK",
                            "Coexisting driver gene abnormalities: ROS1",
                            "Coexisting driver gene abnormalities: NTRK"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KK-LC-1 gene expression",
                            "KK-LC-1 protein expression"
                        ],
                        [
                            "HLA-A*01:01 HLA"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "HR positive expression",
                            "HER2 negative expression"
                        ],
                        [
                            "HER2 positive expression"
                        ],
                        [
                            "TNBC expression"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Central nervous system metastasis pathway alteration",
                            "more than two chemotherapy regimens gene pathway alterations",
                            "allergic history to regimen components protein status",
                            "serious harm to study safety protein status",
                            "uncontrollable heart disease pathway alteration",
                            "hypertension pathway alteration"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PALB2 mutation (somatic)"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "PALB2 mutation (germline)"
                        ],
                        [
                            "BRCA1 mutation (germline)"
                        ],
                        [
                            "BRCA2 mutation (germline)"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR L858R",
                            "mutation"
                        ],
                        [
                            "EGFR exon 19 deletion",
                            "mutation"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "T790M positive",
                            "(somatic)"
                        ],
                        [
                            "T790M",
                            "(germline)"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR L858R"
                        ],
                        [
                            "EGFR del19"
                        ],
                        [
                            "EGFR T790M"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "MET amplification"
                        ],
                        [
                            "EGFR mutations other than EGFR del19, p.L858R or p.T790M"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD19 expression"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Hepatitis B positive status"
                        ],
                        [
                            "Hepatitis C positive status"
                        ],
                        [
                            "HIV positive status"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "HER2 amplification"
                        ],
                        [
                            "HER2 CEP17 ratio \u22652.0"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Prior therapy resulting in cumulative epirubicin dose \u2265 900mg/m2 or cumulative doxorubicin dose \u2265 500mg/m2 or equivalent dose of another anthracycline"
                        ],
                        [
                            "Prior therapy with ado-trastuzumab emtansine (patients who had prior trastuzumab or other HER2 targeted agents are eligible)"
                        ],
                        [
                            "Symptomatic congestive heart failure (New York Heart Association Classification II-IV)"
                        ],
                        [
                            "Myocardial infarction or unstable angina within 6 months of enrollment"
                        ],
                        [
                            "Unstable ventricular arrhythmia requiring treatment"
                        ],
                        [
                            "Grade 3 or worse peripheral neuropathy as defined by CTCAE v4.1"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PDGFRA D842V mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CCNE1 copy number amplification"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "B-cell malignancies",
                            "WM (Waldenstrom macroglobulinemia)",
                            "FL (Follicular lymphoma)",
                            "MCL (Mantle cell lymphoma)",
                            "MZL (Marginal zone lymphoma)",
                            "DLBCL (Diffuse large B-cell lymphoma)",
                            "HCL (Hairy cell leukemia)",
                            "CLL (Chronic lymphocytic leukemia)",
                            "SLL (Small lymphocytic lymphoma)",
                            "Low-grade B-cell lymphomas (follicular Grade 1, 2, or 3A, marginal zone, or small lymphocytic lymphoma)"
                        ],
                        [
                            "Adequate coagulation, renal, and hepatic function",
                            "Activated partial thromboplastin time (APTT) not to exceed 1.5 \u00d7 ULN",
                            "Prothrombin time (PT) not to exceed 1.5 \u00d7 ULN",
                            "Calculated creatinine clearance (CrCl) \u2265 60 mL/min",
                            "Aspartate aminotransferase (AST) \u2264 1.5 \u00d7 ULN",
                            "Alanine aminotransferase (ALT) \u2264 1.5 \u00d7 ULN",
                            "Bilirubin \u2264 1.5 \u00d7 ULN (except subjects with Gilbert's Syndrome)",
                            "Adequate bone marrow independent of growth factor support",
                            "Absolute Neutrophil Count (ANC) \u22651000/uL",
                            "Platelet count \u2265 50,000/\u00b5L OR Platelet count \u2265 20,000/ \u00b5L if thrombocytopenia is due to CLL disease",
                            "Hemoglobin \u22658.0g/dL"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Steroid therapy at dosages equivalent to prednisone >20 mg/day for anti-neoplastic intent within 7 days prior to the first dose of study drug",
                            "Cytochrome P450, family 3, subfamily A (CYP3A4) strong inhibitors and strong CYP2C8 inducers/inhibitors within 7 days prior to the first dose of study drug",
                            "Potent CYP3A4 inducers such as rifampin, carbamazepine, phenytoin, and St. John's wort within 7 days prior to the first dose of study drug",
                            "Treatment with systemic acid-reducing agents including H-2-receptor antagonists and proton pump inhibitors within 7 days prior to the first dose of study drug",
                            "Significant screening electrocardiogram (ECG) abnormalities including 2nd degree AV block type II, 3rd degree block, Grade 2 or higher bradycardia, and corrected QT interval (QTc) \u2265 480ms",
                            "Serum amylase > 1.5 \u00d7 ULN or serum lipase > 1.5 \u00d7 ULN",
                            "History of Richter's transformation for Phase 1a portion of the trial",
                            "Autologous/allogeneic hematopoietic stem cell transplantation (HSCT) therapy within 90 days of the first dose of LP-168",
                            "Active malignancies other than B-cell malignancies within the past 3 years prior to study entry, with exceptions",
                            "Anticoagulation with Warfarin"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "JAK2 V617 mutation"
                        ],
                        [
                            "FLT3 kinase"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CBFB MYH11",
                            "inv(16)(p13.1q22)",
                            "t(16;16)(p13.1;q22)"
                        ],
                        [
                            "RUNX1 RUNX1T1",
                            "t(8;21)(q22;q22.1)"
                        ],
                        [
                            "FLT3",
                            "NPM1",
                            "CEBPa"
                        ],
                        [
                            "myelodysplasia-related changes"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "previous chemotherapy for AML"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "Philadelphia chromosome (Ph) positive",
                            "BCR-ABL positive"
                        ],
                        [
                            "Clonal evolution"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "New York Heart Association (NYHA) cardiac class 3-4 heart disease",
                            "uncontrolled angina within 3 months",
                            "diagnosed or suspected congenital long QT syndrome",
                            "any history of clinically significant ventricular arrhythmias",
                            "prolonged corrected QT (QTc) interval on pre-entry electrocardiogram (> 460 msec)"
                        ],
                        [
                            "Diagnosed congenital bleeding disorders (e.g., von Willebrand's disease)",
                            "diagnosed acquired bleeding disorder within one year (e.g., acquired anti-factor VIII antibodies)"
                        ],
                        [
                            "Active uncontrolled psychiatric disorders include: psychosis",
                            "major depression",
                            "bipolar disorders"
                        ],
                        [
                            "Known to be positive for human immunodeficiency virus (HIV)"
                        ],
                        [
                            "Late chronic phase",
                            "accelerated phase CML",
                            "blast phase",
                            "presence of any of the following features: peripheral or marrow blasts 15% or more",
                            "peripheral or marrow basophils 20% or more",
                            "thrombocytopenia < 100 x 10^9/L unrelated to therapy",
                            "documented extramedullary blastic disease outside liver or spleen"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "ALK alteration",
                            "WHO performance status of 0-2",
                            "Absolute neutrophil count (ANC) \u22651.5 x 10^9/L",
                            "Hemoglobin (Hgb) \u2265 8 g/dL",
                            "Platelets \u226575 x 10^9/L",
                            "Serum total bilirubin \u2264 1.5 x upper limit of normal (ULN)",
                            "Aspartate transaminase (AST) \u2264 3.0 x ULN",
                            "Alanine transaminase (ALT) \u22643.0 x ULN",
                            "alkaline phosphatase (ALP) \u2264 5.0 x ULN",
                            "Serum creatinine <1.5 mg/dL",
                            "Serum amylase \u2264 2 x ULN",
                            "Serum lipase \u2264 ULN",
                            "Fasting plasma glucose \u2264175 mg/dL (\u22649.8 mmol/L)"
                        ],
                        [
                            "Potassium within normal limits",
                            "Magnesium within normal limits",
                            "Phosphorus within normal limits",
                            "Total calcium (corrected for serum albumin) within normal limits"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "History of pancreatitis",
                            "Other concurrent severe, acute, or chronic and/or uncontrolled medical conditions",
                            "Received thoracic radiotherapy \u22644 weeks prior to starting the study treatment",
                            "Known history of interstitial lung disease",
                            "Clinically significant, uncontrolled heart disease and/or recent cardiac event",
                            "Known hypersensitivity to any excipients of LDK378",
                            "Impaired GI function or GI disease",
                            "Participating in other ongoing trials",
                            "Receiving medications that meet specific criteria",
                            "Sexually active males not using a condom",
                            "Women of child-bearing potential not using highly effective methods of contraception"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR mutation"
                        ],
                        [
                            "EGFR C797S",
                            "EGFR T790M",
                            "EGFR 19del",
                            "EGFR 21L858R"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "chemotherapy",
                            "molecularly targeted therapy",
                            "radiotherapy",
                            "biotherapy",
                            "hormone therapy",
                            "vaccine therapy",
                            "immune-checkpoint inhibitor therapy"
                        ],
                        [
                            "radical radiotherapy",
                            "local palliative radiotherapy for bone metastatic lesions"
                        ],
                        [
                            "strong CYP3A inhibitors",
                            "moderate CYP3A inhibitors",
                            "strong CYP2B6 inhibitors",
                            "strong CYP1A2 inhibitors",
                            "strong CYP3A inducers"
                        ],
                        [
                            "systemic therapies for active bacterial, fungal, or viral infection"
                        ],
                        [
                            "major operation in the 3 weeks prior to the start of study treatment"
                        ],
                        [
                            "chronic diarrhea"
                        ],
                        [
                            "> CTCAE Grade 1 continuous diarrhea within the 1 week prior to the first dose"
                        ],
                        [
                            "serious respiratory disorders"
                        ],
                        [
                            "symptomatic metastasis to central nervous system (CNS)",
                            "meningitis carcinomatosa"
                        ],
                        [
                            "clinically significant cardiovascular and cerebrovascular diseases"
                        ],
                        [
                            "clinically uncontrolled serous effusion"
                        ],
                        [
                            "active gastrointestinal disorders"
                        ],
                        [
                            "serious allergy to the study drug or any excipient of the drug"
                        ],
                        [
                            "known HIV positive result",
                            "treponema pallidum antibody positive result"
                        ],
                        [
                            "HBsAg positive result",
                            "HBV DNA > 2000 IU/mL",
                            "HCV antibody positive",
                            "HCV RNA positive results"
                        ],
                        [
                            "other malignancies in the 2 years prior to the study enrollment"
                        ],
                        [
                            "pregnant",
                            "lactating"
                        ],
                        [
                            "existing serious or unstable diseases",
                            "psychiatric disorders",
                            "any disease or medical condition which may have an adverse impact on the subject safety"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "microsatellite instability-high (MSI-H)",
                            "mismatch repair deficient cancer"
                        ],
                        [
                            "tumor mutation burden-high (TMB-H) \u2265 10 mutations/megabase"
                        ],
                        [
                            "HER2+ breast cancer",
                            "HER2+ gastric cancer",
                            "any other HER2+ solid tumor"
                        ],
                        [
                            "CRC with KRAS mutation",
                            "CRC with NRAS mutation"
                        ],
                        [
                            "HNSCC"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "ECOG performance status \u2265 2"
                        ],
                        [
                            "Left-ventricular ejection fraction < 45%"
                        ],
                        [
                            "Known active central nervous system (CNS) involvement by malignancy",
                            "non-malignant CNS disease"
                        ],
                        [
                            "Currently receiving or likely to require immunosuppressive therapy",
                            "active bacterial infections",
                            "active fungal infections",
                            "active viral infections including hep B",
                            "active viral infections including Hep C",
                            "active viral infections including HIV",
                            "known allergy to albumin (human)",
                            "known allergy to DMSO"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PIK3CA activating mutation"
                        ],
                        [
                            "PTEN loss"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Type I diabetes"
                        ],
                        [
                            "Uncontrolled Type II diabetes mellitus (HbA1c > 7.5%)"
                        ],
                        [
                            "Type II diabetes requiring treatment with a sulfonylurea, meglitinide, or insulin"
                        ],
                        [
                            "Uncontrolled hypertension, i.e., blood pressure (BP) of \u2265 150/90; patients who have a history of hypertension controlled by medication must be on a stable dose (for at least one month) and meet all other inclusion criteria."
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "ABL kinase region mutations",
                            "F317L mutation",
                            "V299L mutation"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Y253F mutation"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS G12A"
                        ],
                        [
                            "KRAS G12D"
                        ],
                        [
                            "KRAS G12R"
                        ],
                        [
                            "KRAS G12S"
                        ],
                        [
                            "KRAS G12V"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "KRAS G12C"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "NF1 alteration"
                        ],
                        [
                            "Glioma pathway alteration"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS G12C mutation"
                        ],
                        [
                            "Pathway alteration (RAS, MAPK, SOS1)"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Previous treatment with RAS, MAPK, or SOS1 targeting agents"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR activating mutations (exon 19 deletion, L858R in exon 21)"
                        ],
                        [
                            "Uncommon EGFR mutations (exon 18-21, excluding 19del, 21L858R, 20 insertion, 20T790M, 19L747S, 19L747P, D761Y, 21T854A)"
                        ],
                        [
                            "G719X",
                            "18 deletion",
                            "E709X",
                            "V689M",
                            "S720P",
                            "P699S",
                            "N700D",
                            "E709Q",
                            "G721A",
                            "V740A",
                            "L718P",
                            "I744_K745insKIPVAI",
                            "K745_E746insIPVAIK",
                            "K745_E746insVPVAIK",
                            "K745_E746insTPVAIK",
                            "S768I",
                            "V765A",
                            "T783A",
                            "V774A",
                            "S784P",
                            "R776C",
                            "R776H",
                            "V765M",
                            "G779C",
                            "G779F",
                            "G779S",
                            "T783A",
                            "T783I",
                            "L798F",
                            "L798H",
                            "K806E",
                            "Q812R",
                            "L814P",
                            "L861Q",
                            "R831H",
                            "V834I",
                            "L838P",
                            "complex mutations"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Small cell lung cancer"
                        ],
                        [
                            "Patients who have received EGFR-TKIs"
                        ],
                        [
                            "19 deletion",
                            "21L858R",
                            "20 insertion",
                            "20T790M",
                            "L747S",
                            "L747P",
                            "D761Y",
                            "T854A"
                        ],
                        [
                            "Factors affecting oral medication (dysphagia, gastrointestinal resection, chronic diarrhea, intestinal obstruction)"
                        ],
                        [
                            "Brain metastases"
                        ],
                        [
                            "History of psychotropic drug abuse, mental disorders"
                        ],
                        [
                            "Severe allergies (\u2265 grade 3) to active ingredients and excipients of dacomitinib"
                        ],
                        [
                            "Other malignant tumors"
                        ],
                        [
                            "Ineligible to be enrolled as evaluated by the investigator"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR exon 19 deletion"
                        ],
                        [
                            "EGFR L858R"
                        ],
                        [
                            "EGFR L861Q"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "EGFR TKI"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD79B alteration"
                        ],
                        [
                            "Cyclin D1 alteration"
                        ],
                        [
                            "t(11;14) translocation"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "CD20 negative status at relapse or progression"
                        ],
                        [
                            "Prior allogeneic SCT"
                        ],
                        [
                            "Completion of autologous SCT =< 100 days prior to registration"
                        ],
                        [
                            "Radioimmunoconjugate =< 12 weeks prior to registration"
                        ],
                        [
                            "Monoclonal antibody or antibody-drug conjugate therapy within 5 half-lives or 4 weeks prior to registration, whichever is longer"
                        ],
                        [
                            "Radiotherapy, chemotherapy, hormonal therapy, or targeted small-molecule therapy within 2 weeks prior to registration (with the exception of ibrutinib to prevent tumor flare, patients taking ibrutinib who are progressing must discontinue ibrutinib 2 half-lives or 2 days prior to initiating protocol therapy)"
                        ],
                        [
                            "Clinically significant toxicity from prior therapy that has not resolved to grade =< 2 (per NCI CTCAE version v5.0) prior to registration"
                        ],
                        [
                            "Current grade > 1 peripheral neuropathy"
                        ],
                        [
                            "Any history of CNS lymphoma or leptomeningeal infiltration"
                        ],
                        [
                            "Treatment with systemic corticosteroids > 20 mg/day prednisone or equivalent Patients who are receiving corticosteroids =< 20 mg/day, prednisone or equivalent, for non-lymphoma treatment reasons must be documented to be on a stable dose for at >= 4 weeks prior to registration. If corticosteroid treatment is urgently required for lymphoma symptom control prior to the start of study treatment, up to 100 mg/day of prednisone or equivalent can be given for a maximum of 5 days, but all tumor assessments must be completed prior to start of corticosteroid treatment"
                        ],
                        [
                            "History of severe allergic or anaphylactic reaction or known sensitivity to humanized or murine monoclonal antibodies rituximab, polatuzumab vedotin, and venetoclax"
                        ],
                        [
                            "Requirement for warfarin treatment (because of potential DDIs that may increase the exposure of warfarin)"
                        ],
                        [
                            "Treatment with the following agents =< 7 days prior to registration"
                        ],
                        [
                            "Strong and moderate CYP3A inhibitors such as fluconazole, ketoconazole, and clarithromycin"
                        ],
                        [
                            "Strong and moderate CYP3A inducers such as rifampin and carbamazepine. If taking proton pump inhibitors willing to avoid co-administration and stagger venetoclax dosing"
                        ],
                        [
                            "Consumption of grapefruit, grapefruit products, Seville oranges (including marmalade that contains Seville oranges), or star fruit =< 3 days prior to registration"
                        ],
                        [
                            "Clinically significant history of liver disease, including viral or other hepatitis, current alcohol abuse, or cirrhosis"
                        ],
                        [
                            "Active hepatitis B or hepatitis C infection. Patients who have been successfully treated and cleared their virus as evidenced a negative Hep B or Hep C PCR are eligible"
                        ],
                        [
                            "Known history of HIV positive status or known infection with human T-cell leukemia virus 1. For patients with unknown HIV status, HIV testing will be performed at screening if required by local regulations"
                        ],
                        [
                            "History of PML"
                        ],
                        [
                            "Vaccination with a live virus vaccine =< 28 days prior to registration"
                        ],
                        [
                            "History of other malignancy that could affect compliance with the protocol or interpretation of results, with the exception of the following: curatively treated carcinoma in situ of the cervix, good-prognosis ductal carcinoma in situ of the breast, basal- or squamous-cell skin cancer, stage I melanoma, or low-grade, early-stage localized prostate cancer"
                        ],
                        [
                            "Any previously treated malignancy that has been in remission without treatment for =< 3 years prior to registration"
                        ],
                        [
                            "Evidence of any significant, uncontrolled concomitant disease that could affect compliance with the protocol or interpretation of results, including significant cardiovascular disease or significant pulmonary disease"
                        ],
                        [
                            "Major surgical procedure other than for diagnosis =< 28 days prior to day 1 of cycle 1, or anticipation of a major surgical procedure during the course of the study"
                        ],
                        [
                            "Inability or unwillingness to swallow pills"
                        ],
                        [
                            "History of malabsorption syndrome or other condition that would interfere with enteral absorption"
                        ],
                        [
                            "History of inflammatory bowel disease or active bowel inflammation"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": [
                        [
                            "ERK inhibitor PD",
                            "CNS malignant tumor",
                            "CNS metastasis",
                            "other malignant tumor within 2 years",
                            "clinically significant liver disease",
                            "CYP3A potent inducer use within 2 weeks",
                            "CYP3A P-gp potent inhibitor use within one week",
                            "sensitive substrate P-gp BCRP MATE 2-K CYP3A CYP2C8/OATP1B1 CYP2D6/CYP3A use within one week",
                            "Hereditary long QT syndrome",
                            "QTcF>480 msec",
                            "serious arrhythmia",
                            "conduction abnormality",
                            "impaired cardiac function",
                            "clinically significant cardiac disease",
                            "New York Heart Association (NYHA) Grade III/IV congestive heart failure",
                            "left ventricular ejection fraction (LVEF) <50%",
                            "uncontrollable hypertension",
                            "multiple factors affecting absorption distribution metabolism or excretion of oral drugs",
                            "retinopathy",
                            "any disease metabolic abnormality physical examination abnormality or clinically significant laboratory examination abnormality that may affect patient's compliance or suitability for study drug use"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD276 (B7-H3) expression"
                        ],
                        [
                            "Body weight \u2265 10 kg"
                        ],
                        [
                            "Life expectancy: at least 8 weeks"
                        ],
                        [
                            "Karnofsky/jansky score \u2265 60%"
                        ],
                        [
                            "Left ventricular ejection fraction \u2265 40/55%"
                        ],
                        [
                            "Pulse Ox \u2265 90%"
                        ],
                        [
                            "Liver function: ALT negative 3x ULN",
                            "AST negative 3x ULN",
                            "serum bilirubin negative 2x ULN",
                            "alkaline phosphatase negative 2x ULN"
                        ],
                        [
                            "Renal function: serum creatinine negative 3x ULN"
                        ],
                        [
                            "Marrow function: White blood cell count \u22651000/ul",
                            "Absolute neutrophil count \u2265500/ul",
                            "Absolute lymphocyte count \u2265500/ul",
                            "Platelet count \u226525,000/ul"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Existing severe illness",
                            "major organ dysfunction",
                            "grade 3 hematologic toxicity"
                        ],
                        [
                            "Untreated central nervous system (CNS) metastasis"
                        ],
                        [
                            "Previous treatment with other genetically engineered CD276-CAR T cells",
                            "CD276 antibody therapy"
                        ],
                        [
                            "Patients who require systemic corticosteroid",
                            "other immunosuppressive therapy"
                        ],
                        [
                            "Evidence of tumor potentially causing airway obstruction"
                        ],
                        [
                            "Inability to comply with protocol requirements"
                        ],
                        [
                            "Insufficient CAR T cells availability"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS G12V (mutation, somatic)"
                        ],
                        [
                            "HLA-DRB1*07:01"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR expression"
                        ],
                        [
                            "MSI-L status"
                        ],
                        [
                            "dMMR pathway alteration"
                        ],
                        [
                            "PD-L1 negative status"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "CNS metastases"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": [
                        [
                            "CNS metastasis",
                            "hepatitis B",
                            "hepatitis C",
                            "HIV",
                            "organ transplantation",
                            "severe allergy",
                            "clinical trial drugs",
                            "major surgery",
                            "minor surgical procedures",
                            "high blood pressure",
                            "active infection",
                            "hemoptysis",
                            "arterial thromboembolic events",
                            "venous thrombosis",
                            "bleeding disorders",
                            "jaundice",
                            "COPD",
                            "abdominal hernia",
                            "gastrointestinal perforation",
                            "esophageal varices",
                            "cardiovascular diseases",
                            "gastrointestinal disorders",
                            "hereditary nonpolyposis colorectal cancer",
                            "intestinal perforation",
                            "warfarin use",
                            "platelet function inhibitors",
                            "neurological dysfunction"
                        ]
                    ]
                }
            ],
            "Actual": [
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "NPM1 alteration"
                        ],
                        [
                            "KMT2A alteration"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "ALK translocation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "BRAF mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD30 positive"
                        ],
                        [
                            "CD30 expression"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "HR positive",
                            "HER2 negative",
                            "PIK3CA mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PD-L1 expression"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "EGFR mutation"
                        ],
                        [
                            "EGFR rearrangement"
                        ],
                        [
                            "EGFR translocation"
                        ],
                        [
                            "ALK mutation"
                        ],
                        [
                            "ALK rearrangement"
                        ],
                        [
                            "ALK translocation"
                        ],
                        [
                            "ROS1 mutation"
                        ],
                        [
                            "ROS1 rearrangement"
                        ],
                        [
                            "ROS1 translocation"
                        ],
                        [
                            "BRAF V600E"
                        ],
                        [
                            "NTRK mutation"
                        ],
                        [
                            "NTRK rearrangement"
                        ],
                        [
                            "NTRK translocation"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD19 expression"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PIK3CA mutation"
                        ],
                        [
                            "PIK3CB mutation"
                        ],
                        [
                            "PIK3CD mutation"
                        ],
                        [
                            "PIK3CG mutation"
                        ],
                        [
                            "PIK3R1 mutation"
                        ],
                        [
                            "PIK3R2 mutation"
                        ],
                        [
                            "PIK3R3 mutation"
                        ],
                        [
                            "PIK3C2G mutation"
                        ],
                        [
                            "PIK3C3 mutation"
                        ],
                        [
                            "INPP4A mutation"
                        ],
                        [
                            "INPP4B mutation"
                        ],
                        [
                            "INPPL1 mutation"
                        ],
                        [
                            "INPP5D mutation"
                        ],
                        [
                            "PTEN mutation"
                        ],
                        [
                            "AKT1 mutation"
                        ],
                        [
                            "AKT2 mutation"
                        ],
                        [
                            "AKT3 mutation"
                        ],
                        [
                            "MTOR mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "RET alteration"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "Primary driver alteration"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "MTAP homozygous deletion"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "FGFR1 fusion"
                        ],
                        [
                            "FGFR2 fusion"
                        ],
                        [
                            "FGFR3 fusion"
                        ],
                        [
                            "FGFR1 P150S"
                        ],
                        [
                            "FGFR1 T340M"
                        ],
                        [
                            "FGFR1 R445W"
                        ],
                        [
                            "FGFR1 N546K"
                        ],
                        [
                            "FGFR1 K656E"
                        ],
                        [
                            "FGFR2 C62Y"
                        ],
                        [
                            "FGFR2 A67V"
                        ],
                        [
                            "FGFR2 N82K"
                        ],
                        [
                            "FGFR2 D101Y"
                        ],
                        [
                            "FGFR2 E160K"
                        ],
                        [
                            "FGFR2 E163K"
                        ],
                        [
                            "FGFR2 M186T"
                        ],
                        [
                            "FGFR2 R203H"
                        ],
                        [
                            "FGFR2 R210Q"
                        ],
                        [
                            "FGFR2 Q212K"
                        ],
                        [
                            "FGFR2 R251Q"
                        ],
                        [
                            "FGFR2 S252W"
                        ],
                        [
                            "FGFR2 P253R"
                        ],
                        [
                            "FGFR2 P253L"
                        ],
                        [
                            "FGFR2 A264T"
                        ],
                        [
                            "FGFR2 W290C"
                        ],
                        [
                            "FGFR2 K310R"
                        ],
                        [
                            "FGFR2 Y328N"
                        ],
                        [
                            "FGFR2 G364E"
                        ],
                        [
                            "FGFR2 Y375C"
                        ],
                        [
                            "FGFR2 C382R"
                        ],
                        [
                            "FGFR2 A389T"
                        ],
                        [
                            "FGFR2 V392A"
                        ],
                        [
                            "FGFR2 R399Q"
                        ],
                        [
                            "FGFR2 H416R"
                        ],
                        [
                            "FGFR2 I422V"
                        ],
                        [
                            "FGFR2 H544Q"
                        ],
                        [
                            "FGFR2 N549H"
                        ],
                        [
                            "FGFR2 N549K"
                        ],
                        [
                            "FGFR2 N549D"
                        ],
                        [
                            "FGFR2 N549S"
                        ],
                        [
                            "FGFR2 L560F"
                        ],
                        [
                            "FGFR2 K659E"
                        ],
                        [
                            "FGFR2 K659N"
                        ],
                        [
                            "FGFR2 R664W"
                        ],
                        [
                            "FGFR2 E718K"
                        ],
                        [
                            "FGFR2 S791T"
                        ],
                        [
                            "FGFR3 G380E"
                        ],
                        [
                            "FGFR3 G380R"
                        ],
                        [
                            "FGFR3 A391E"
                        ],
                        [
                            "FGFR3 K650T"
                        ],
                        [
                            "FGFR3 K650E"
                        ],
                        [
                            "FGFR3 K650Q"
                        ],
                        [
                            "FGFR3 K650N"
                        ],
                        [
                            "FGFR1 activating mutation"
                        ],
                        [
                            "FGFR2 activating mutation"
                        ],
                        [
                            "FGFR3 activating mutation"
                        ],
                        [
                            "FGFR1 amplification"
                        ],
                        [
                            "FGFR2 amplification"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "FGFR1 V561"
                        ],
                        [
                            "FGFR2 V564"
                        ],
                        [
                            "FGFR2 V565"
                        ],
                        [
                            "FGFR3 V555"
                        ],
                        [
                            "FGFR3 V557"
                        ],
                        [
                            "FGFR4 V550"
                        ],
                        [
                            "KRAS mutation"
                        ],
                        [
                            "NRAS mutation"
                        ],
                        [
                            "EGFR mutation"
                        ],
                        [
                            "BRAF V600"
                        ],
                        [
                            "ALK translocation"
                        ],
                        [
                            "ROS1 translocation"
                        ],
                        [
                            "NTRK translocation"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KK-LC-1 expression",
                            "HLA-A*01:01"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "HR positive",
                            "HER2 negative"
                        ],
                        [
                            "HER2 positive"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PALB2 mutatuon"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "PALB2 variants of undetermined significance"
                        ],
                        [
                            "BRCA1 mutation (germline)"
                        ],
                        [
                            "BRCA1 mutation (somatic)"
                        ],
                        [
                            "BRCA2 mutation (germline)"
                        ],
                        [
                            "BRCA2 mutation (somatic)"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR mutation"
                        ],
                        [
                            "EGFR L858R"
                        ],
                        [
                            "EGFR exon 19 deletion"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "EGFR T790M"
                        ],
                        [
                            "EGFR T790M (germline)"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR p.L858R"
                        ],
                        [
                            "EGFR del19"
                        ],
                        [
                            "EGFR p.T790M"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "MET amplification"
                        ],
                        [
                            "EGFR mutation"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD19 positive"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "HER2 mutation"
                        ],
                        [
                            "HER2 exon 20 insYVMA"
                        ],
                        [
                            "HER2 exon 20 insGSP"
                        ],
                        [
                            "HER2 exon 20 insTGT"
                        ],
                        [
                            "HER2 L755A"
                        ],
                        [
                            "HER2 L755S"
                        ],
                        [
                            "HER2 V777L"
                        ],
                        [
                            "HER2 V659E"
                        ],
                        [
                            "HER2 S310F"
                        ],
                        [
                            "HER2 amplification"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PDGFRA exon 18 mutation"
                        ],
                        [
                            "PDGFRA D842V"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CCNE1 copy number amplification"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "inv(16)(p13.1q22)"
                        ],
                        [
                            "t(16;16)(p13.1;q22)"
                        ],
                        [
                            "CBFB-MYH11"
                        ],
                        [
                            "t(8;21)(q22;q22.1)"
                        ],
                        [
                            "RUNX1-RUNX1T1"
                        ],
                        [
                            "FLT3 mutation"
                        ],
                        [
                            "NPM1 mutation"
                        ],
                        [
                            "CEBPa mutation"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "t(9;22)"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "Philadelphia chromosome positive"
                        ],
                        [
                            "BCR-ABL positive"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "ALK positive"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR mutation"
                        ],
                        [
                            "EGFR C797S"
                        ],
                        [
                            "EGFR T790M"
                        ],
                        [
                            "EGFR 19del"
                        ],
                        [
                            "EGFR 21L858R"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "microsatellite instability-high"
                        ],
                        [
                            "mismatch repair deficient"
                        ],
                        [
                            "HER2 positive"
                        ],
                        [
                            "KRAS mutation"
                        ],
                        [
                            "NRAS mutation"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "PIK3CA activating mutation"
                        ],
                        [
                            "PTEN loss"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "Philadelphia chromosome of t (9;22) translocation"
                        ],
                        [
                            "BCR-ABL1 P210"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "ABL T315I"
                        ],
                        [
                            "ABL Y253F"
                        ],
                        [
                            "ABL Y253H"
                        ],
                        [
                            "ABL E255K"
                        ],
                        [
                            "ABL E255V"
                        ],
                        [
                            "ABL F359C"
                        ],
                        [
                            "ABL F359V"
                        ],
                        [
                            "ABL F359I"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS p.G12A"
                        ],
                        [
                            "KRAS p.G12D"
                        ],
                        [
                            "KRAS p.G12R"
                        ],
                        [
                            "KRAS p.G12S"
                        ],
                        [
                            "KRAS p.G12V"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "KRAS p.G12C"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS G12C"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR activating mutation"
                        ],
                        [
                            "EGFR uncommon mutation"
                        ],
                        [
                            "EGFR exon 18 mutation"
                        ],
                        [
                            "EGFR exon 19 mutation"
                        ],
                        [
                            "EGFR exon 20 mutation"
                        ],
                        [
                            "EGFR exon 21 mutation"
                        ],
                        [
                            "EGFR G719A"
                        ],
                        [
                            "EGFR G719C"
                        ],
                        [
                            "EGFR G719S"
                        ],
                        [
                            "EGFR G719D"
                        ],
                        [
                            "EGFR G719E"
                        ],
                        [
                            "EGFR 18del"
                        ],
                        [
                            "EGFR E709G"
                        ],
                        [
                            "EGFR E709M"
                        ],
                        [
                            "EGFR E709V"
                        ],
                        [
                            "EGFR E709H"
                        ],
                        [
                            "EGFR E709DA"
                        ],
                        [
                            "EGFR E709DK"
                        ],
                        [
                            "EGFR V689M"
                        ],
                        [
                            "EGFR S720P"
                        ],
                        [
                            "EGFR S720F"
                        ],
                        [
                            "EGFR P699S"
                        ],
                        [
                            "EGFR N700D"
                        ],
                        [
                            "EGFR E709Q"
                        ],
                        [
                            "EGFR G721A"
                        ],
                        [
                            "EGFR V740A"
                        ],
                        [
                            "EGFR L718P"
                        ],
                        [
                            "EGFR I744_K745insKIPVAI"
                        ],
                        [
                            "EGFR K745_E746insIPVAIK"
                        ],
                        [
                            "EGFR K745_E746insVPVAIK"
                        ],
                        [
                            "EGFR K745_E746insTPVAIK"
                        ],
                        [
                            "EGFR S768I"
                        ],
                        [
                            "EGFR V765A"
                        ],
                        [
                            "EGFR T783A"
                        ],
                        [
                            "EGFR V774A"
                        ],
                        [
                            "EGFR S784P"
                        ],
                        [
                            "EGFR R776C"
                        ],
                        [
                            "EGFR R776H"
                        ],
                        [
                            "EGFR V765M"
                        ],
                        [
                            "EGFR G779C"
                        ],
                        [
                            "EGFR G779F"
                        ],
                        [
                            "EGFR G779S"
                        ],
                        [
                            "EGFR T783I"
                        ],
                        [
                            "EGFR L798F"
                        ],
                        [
                            "EGFR L798H"
                        ],
                        [
                            "EGFR K806E"
                        ],
                        [
                            "EGFR Q812R"
                        ],
                        [
                            "EGFR L814P"
                        ],
                        [
                            "EGFR L861Q"
                        ],
                        [
                            "EGFR R831H"
                        ],
                        [
                            "EGFR V834I"
                        ],
                        [
                            "EGFR L838P"
                        ],
                        [
                            "EGFR L861R"
                        ],
                        [
                            "EGFR 18G719A+20S768I"
                        ],
                        [
                            "EGFR 18 E709X+21L861Q"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "EGFR 19del+21L861Q"
                        ],
                        [
                            "EGFR 18G719X+21L858R"
                        ],
                        [
                            "EGFR exon 19 deletion"
                        ],
                        [
                            "EGFR exon 21 L858R"
                        ],
                        [
                            "EGFR 20 insertion"
                        ],
                        [
                            "EGFR exon 20 T790M"
                        ],
                        [
                            "EGFR L747S"
                        ],
                        [
                            "EGFR L747P"
                        ],
                        [
                            "EGFR D761Y"
                        ],
                        [
                            "EGFR T854A"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR mutation"
                        ],
                        [
                            "EGFR exon 19 deletion"
                        ],
                        [
                            "EGFR L858R"
                        ],
                        [
                            "EGFR L861Q"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "cyclin D1 positive"
                        ],
                        [
                            "t(11;14) positive"
                        ]
                    ],
                    "exclusion_biomarker": [
                        [
                            "CD20 negative"
                        ]
                    ]
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "CD276 expression"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "KRAS G12V",
                            "HLA class II match"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [
                        [
                            "EGFR expression"
                        ],
                        [
                            "MSI low"
                        ],
                        [
                            "DNA mismatch repair proficient"
                        ]
                    ],
                    "exclusion_biomarker": []
                },
                {
                    "inclusion_biomarker": [],
                    "exclusion_biomarker": []
                }
            ],
            "Failed": [],
            "tp_inclusion": [
                0,
                2,
                1,
                0,
                0,
                1,
                1,
                0,
                0,
                1,
                0,
                0,
                1,
                18,
                1,
                1,
                5,
                0,
                0,
                0,
                0,
                0,
                2,
                1,
                0,
                1,
                0,
                0,
                1,
                0,
                0,
                3,
                1,
                0,
                5,
                1,
                2,
                0,
                0,
                0,
                0,
                0,
                0,
                3,
                0,
                0,
                0,
                0,
                1,
                0
            ],
            "fp_inclusion": [
                7,
                0,
                0,
                1,
                14,
                1,
                0,
                6,
                4,
                0,
                3,
                2,
                0,
                0,
                0,
                0,
                50,
                3,
                4,
                1,
                0,
                0,
                2,
                2,
                1,
                1,
                0,
                1,
                0,
                21,
                2,
                6,
                2,
                17,
                0,
                8,
                0,
                3,
                5,
                2,
                0,
                2,
                40,
                0,
                3,
                0,
                15,
                2,
                3,
                0
            ],
            "tn_inclusion": [
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                1,
                0,
                0,
                0,
                0,
                1,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                0,
                0,
                0,
                0,
                1,
                0,
                0,
                0,
                1
            ],
            "fn_inclusion": [
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                0,
                0,
                2,
                1,
                0,
                0,
                0,
                0,
                0,
                52,
                2,
                3,
                1,
                0,
                0,
                1,
                2,
                1,
                9,
                0,
                2,
                0,
                0,
                0,
                5,
                1,
                1,
                0,
                4,
                0,
                2,
                5,
                0,
                0,
                1,
                55,
                1,
                2,
                0,
                1,
                2,
                2,
                0
            ],
            "tp_exclusion": [
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                2,
                0,
                0,
                0,
                1,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0
            ],
            "tn_exclusion": [
                0,
                1,
                1,
                0,
                0,
                0,
                1,
                0,
                0,
                1,
                0,
                1,
                1,
                1,
                0,
                0,
                0,
                1,
                0,
                0,
                1,
                1,
                0,
                0,
                0,
                0,
                1,
                1,
                1,
                0,
                1,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                1,
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                0,
                0
            ],
            "fp_exclusion": [
                1,
                0,
                0,
                8,
                1,
                5,
                0,
                1,
                13,
                0,
                5,
                0,
                0,
                0,
                0,
                2,
                31,
                0,
                6,
                1,
                0,
                0,
                4,
                1,
                3,
                6,
                0,
                0,
                0,
                10,
                0,
                1,
                18,
                11,
                37,
                12,
                4,
                1,
                1,
                0,
                0,
                1,
                16,
                1,
                28,
                20,
                11,
                0,
                1,
                27
            ],
            "fn_exclusion": [
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                13,
                0,
                0,
                0,
                1,
                0,
                13,
                0,
                0,
                3,
                0,
                0,
                2,
                1,
                0,
                0,
                0,
                0,
                0,
                0,
                0,
                1,
                0,
                0,
                0,
                0,
                0,
                8,
                1,
                0,
                0,
                0,
                10,
                0,
                1,
                0,
                0,
                0,
                0,
                0
            ],
            "Inclusion Precision": [
                0.18466898954703834
            ],
            "Inclusion Recall": [
                0.25
            ],
            "Inclusion F1": [
                0.2124248496993988
            ],
            "Inclusion Acc": [
                0.13053097345132744
            ],
            "Inclusion F2": [
                0.23348017621145375
            ],
            "Exclusion Precision": [
                0.010309278350515464
            ],
            "Exclusion Recall": [
                0.05263157894736842
            ],
            "Exclusion F1": [
                0.017241379310344827
            ],
            "Exclusion Acc": [
                0.055248618784530384
            ],
            "Exclusion F2": [
                0.028901734104046246
            ],
            "Inclusion DNF Precision": [
                0.28346456692913385
            ],
            "Inclusion DNF Recall": [
                0.17391304347826086
            ],
            "Inclusion DNF F1": [
                0.2155688622754491
            ],
            "Inclusion DNF Acc": [
                0.13815789473684212
            ],
            "Inclusion DNF F2": [
                0.18848167539267013
            ],
            "Exclusion DNF Precision": [
                0.02158273381294964
            ],
            "Exclusion DNF Recall": [
                0.05263157894736842
            ],
            "Exclusion DNF F1": [
                0.030612244897959183
            ],
            "Exclusion DNF Acc": [
                0.09523809523809523
            ],
            "Exclusion DNF F2": [
                0.040871934604904625
            ],
            "Latency (seconds)": 588.6307151317596,
            "tokens": 128253
        }
    ]
}